NEPH - Nephros Inc

NEPH - Nephros Inc

https://www.nephros.com

Momentum: Bearish

Recent News

Powered by Alpha Vantage

Nephros Schedules Second Quarter 2025 Financial Results Conference Call - Nephros ( NASDAQ:NEPH )

Benzinga • 1 month, 2 weeks ago • score: 0.57

SOUTH ORANGE, N.J., July 31, 2025 ( GLOBE NEWSWIRE ) -- Nephros, Inc. NEPH, a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its second-quarter financial results on Thursday, August 07, 2025 after market ...

Nephros Delivers Critical Disaster Response to Support Hospitals and Care Facilities Impacted by Hurricanes Helene and Milton

GlobeNewswire • 10 months, 4 weeks ago • score: 0.52

SOUTH ORANGE, N.J., Oct. 17, 2024 ( GLOBE NEWSWIRE ) -- Nephros, Inc. ( Nasdaq: NEPH ) Nephros, Inc., a leader in advanced filtration technology, is proud to announce its rapid response to the recent hurricanes which devastated parts of the southeastern United States.

GEE Group And 2 Other Stocks Under $3 Insiders Are Buying - Presidio Property Trust ( NASDAQ:SQFT )

Benzinga • 1 year, 3 months ago • score: 0.20

The Dow Jones index closed lower by over 300 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading ...

Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results

GlobeNewswire • 1 year, 6 months ago • score: 0.16

Full-Year Net Revenue of $14.2 Million and Fourth-Quarter Net Revenue of $3.3 Million ...

Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results

GlobeNewswire • 1 year, 6 months ago • score: 0.60

SOUTH ORANGE, NJ, Feb. 29, 2024 ( GLOBE NEWSWIRE ) -- via NewMediaWire - Nephros, Inc. ( Nasdaq: NEPH ) , a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its fourth quarter and fiscal year financial ...

Insiders Buying Delcath Systems And 3 Other Penny Stocks - Charles & Colvard ( NASDAQ:CTHR ) , Delcath Systems ( NASDAQ:DCTH )

Benzinga • 1 year, 9 months ago • score: 0.42

The Dow Jones index closed higher by over 150 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading ...

Nephros Announces Results for Quarter Ended September 30, 2023

GlobeNewswire • 1 year, 10 months ago • score: 0.19

Third-Quarter Net Revenue of $3.7 Million, a 55% Increase Over 2022. Net Loss from Continuing Operations Narrows 85% to $0.2 Million. $1.1 Million in Positive Year-to-Date Net Cash Flows from Operating Activities ...

Nephros Hires Judy Krandel as Chief Financial Officer - Nephros ( NASDAQ:NEPH )

Benzinga • 1 year, 10 months ago • score: 0.64

SOUTH ORANGE, NJ, Nov. 01, 2023 ( GLOBE NEWSWIRE ) -- via NewMediaWire - Nephros, Inc. NEPH, a leading water technology company providing filtration solutions to the medical and commercial markets, announced the appointment of Judy Krandel as Chief Financial Officer ( CFO ) , effective today.

Nephros Hires Judy Krandel as Chief Financial Officer

GlobeNewswire • 1 year, 10 months ago • score: 0.53

SOUTH ORANGE, NJ, Nov. 01, 2023 ( GLOBE NEWSWIRE ) -- via NewMediaWire - Nephros, Inc. ( Nasdaq: NEPH ) , a leading water technology company providing filtration solutions to the medical and commercial markets, announced the appointment of Judy Krandel as Chief Financial Officer ( CFO ) , ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Nephros, Inc., a commercial stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company is headquartered in South Orange, New Jersey.

52W High

$5.00

52W Low

$1.36

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.23

Valuation

Rich

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

31.92

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

24.61

EV/Revenue (<3 favorable)

2.20

P/S (TTM) (<3 favorable)

2.43

P/B (<3 favorable)

4.23

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

11.19%

Institutions (25–75% balanced)

45.78%

Shares Outstanding

10,600,600

Float

9,243,800

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

16,684,000

Gross Profit (TTM)

10,573,000

EPS (TTM)

0.12

Profit Margin (>10% good)

0.08%

Operating Margin (TTM) (higher better)

0.06%

ROE (TTM) (>15% strong)

0.15%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.36

Momentum

Bearish momentum

Value

0.1236

Previous

0.1175

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025